오는 2월 6-10일에 서울 강남에서 "9th International Conference on Emerging Infectious Diseases" 국제 심포지엄이 있습니다.
(참석 연자들을 학회 집담회로 따로 초청하여 세미나를 하고 싶었으나 연자들의 바쁜 스케줄로 따로 초청은 하지 않을 예정입니다.)
특히 8일 오후에는 기생충 약제 내성 및 9일 하루 종일 기생충 관련 세션이 있을 예정 (자세한 연자와 발표 제목은 아래 홈피를 참고해 주세요)
아래는 프로그램 내용입니다. 따로 참가비나 등록비는 없은 것으로 파악됩니다.
학술부장 한은택 올림.
U.S.-Japan Cooperative Medical Sciences Program (USJCMSP)
19th International Conference on Emerging Infectious Diseases (EID) in the Pacific Rim
February 7-8, 2017
Venue: Novotel Ambassador Seoul Gangnam
130 Bongeunsa ro
Seoul, Republic of Korea
The focus of this conference is on antimicrobial resistance (AMR) of bacterial and parasitic diseases of importance in the Asia-Pacific region. The objectives of this conference are to share current research findings and foster existing and potential international research collaborations that engage investigators and institutions in the Asia-Pacific region ! and the United States.
If you will be using Twitter or Instagram, please use the hashtag #CMSPEID.
Tuesday, 7 February 2017
8:30-9:10 Japanese Embassy - TBC
U.S. Embassy - Marc Knapper, Charge de Affairs
KCDC/Ministry of Health and Welfare - TBC
International Vaccine Institute (IVI) ? Jerome Kim
USJCMSP ? Aikichi Iwamoto and Patrick Brennan
Introduced by Aikichi Iwamoto, Agency for Medical Research and Development (AMED), Japan
9:10-9:40 Masakatsu Shibasaki,Institute of Microbial Chemistry, Japan
9:40-9:50 Announcement of USJCMSP 2016 Collaborative Awards
SESSION 1 Overview of Antimicrobial Resistance
Moderators: Jong Seok Lee, International TB Research Center, Korea
Kenji Hirayama, Nagasaki University, Japan
Rapporteurs: William Petri, University of Virginia School of Medicine, U.S.A.
Yohei Doi, University of Pittsburgh, U.S.A.
10:00-11:00 Panel Discussion (10 min. talks, followed by discussion)
Topic: NIH/NIAID and CARB: Combating Antibiotic-Resistant Bacteria
Dennis Dixon, National Institute of Allergy and Infectious Diseases (NIAID), U.S.A.
Overview of AMR in Japan
Kazuhiro Tateda, Toho University, Japan
Overview of AMR in Korea
Seok Hoon Jeong, Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Korea
Time for Discussion (30 min.)
11:00-12:00 Lunch Break and Poster Viewing
SESSION 2 Molecular Epidemiology of Antimicrobial Resistance ? shorter talks (20 min. each)
Moderators: Dennis Dixon, NIAID, U.S.A. Keigo Shibayama, NIID, Japan
Rapporteurs: Robert Hall, NIAID, U.S.A. Alison Kraigsley, NIAID, U.S.A.
12:00-12:20 The Global Spread of Fluoroquinolone Resistant Shigella sonnei
Hao Chung The, Oxford University Clinical Research Unit, Vietnam
12:20-12:40 The reemergence of schistosomiasis in Sichuan, China despite treatment and control: integrating next-generation genomics and field epidemiology
Elizabeth Carlton, University of Colorado, Denver, U.S.A.
12:40-13:00 Genetic approaches to cryptosporidiosis a leading cause of global child mortality
Boris Striepen, University of Georgia, Athens, U.S.A.
13:00-13:20 Molecular and phenotypic surveys for multidrug-resistant tuberculosis in South East Asia
Yasuhiko Suzuki, Hokkaido University Research Center for Zoonosis Control, Japan
13:20-13:40 Topic: NGS technology for molecular typing and DST of M. tuberculosis
Jong Seok Lee, International Tuberculosis Research Center, Korea
13:40- 14:00 Global Epidemiology of AMR in Bacteria
Yohei Doi, University of Pittsburg, Japan and U.S.A.
SESSION 3 Genomics and Mechanisms of Antimicrobial Resistance ? shorter talks (20 min each)
Moderators: Tim Murphy, State University of New York (SUNY) at Buffalo, U.S.A.
Mitsuaki Nishibuchi, Kyoto University, Japan
Rapporteurs: Tim Murphy, SUNY, U.S.A. Takushi Kaneko, TB Alliance, U.S.A.
14:30-14:50 Mobile genetic elements in the spread of resistance: overview and current work on the mobile element behind the MRSA epidemic
Phoebe Rice, University of Chicago, U.S.A.
14:50-15:10 Topic: Consequencesof Drug Resistant Mutations on the Whole Genome and Physiology (Fitness)
Yonatan Grad, Harvard School of Public Health, U.S.A.
15:10-15:30 Reactive Oxygen Species Play an Important Role in the Bactericidal Activity of Quinolone Antibiotics
Deepak Nair, Regional Centre for Biotechnology in Faridabad, India
15:30-15:50 Phenotypic variations of L. donovani in Sri Lanka: Threat of antimony resistance?
Nadira Karunaweera, University of Colombo, Sri Lanka
15:50-16:10 Topic: New PK/PD Strategies to Combat Resistance
Brian Tsuji, University at Buffalo, U.S.A.
16:10 ? 16:30 Discussion
Wednesday, 8 February 2017
Introduced by Gray Handley, National Institute of Allergy and Infectious Diseases (NIAID), U.S.A.
8:30-9:00 John Mekalanos, Harvard Medical School, U.S.A.
SESSION 4 New Developments in Recognition and Technologies for Prevention, Diagnosis and Treatment of AMR ? short talks (20 min each)
Moderators: John Mekalanos, Harvard Medical School, U.S.A.
Kiyoshi Kita, Nagasaki University, Japan
Rapporteurs: Steve Reed, U.S.A. Chie Nakajima, Hokkaido University, Japan
9:00-9:20 Efficacy of topical single radio frequency induced heat therapy (RFHT) in treatment of old world SSG-responsive and SSG-refractory CL caused by L. tropica
Abhay Satoskar, Ohio State University, U.S.A.
9:20-9:40 Topic: Diagnostic technology
TBN, bioM?rieux, France
9:40-10:00 Topic: GeneXpert MTB/RIF and other genetic based tools for surveys of AMR in Mycobacterium tuberculosis infections
Linda Xie, National Institute of Allergy and Infectious Diseases, U.S.A.
10:00-10:20 Topic: Colistin Resistance and MCR-1
Yang Wang, China Agricultural University, China
10:20-10:40 Topic: GHIT-Sponsored US-Japan Program and Other Global TB Alliance Programs to
Develop New TB Drugs
Takushi Kaneko, TB Alliance, U.S.A.
10:40-11:00 The microbiome as a tool to prevent transmission and infection due to antimicrobial resistant bacterial pathogens
Melinda Mary Pettigrew, Yale University, U.S.A.
11:00 -11:20 Discussion
SESSION 5 Malaria Elimination and AMR
Moderators: Shigeyuki Kano, National Center for Global Health and Medicine, Japan
Malla Rao, NIAID, U.S.A
Rapporteurs: Nadira Karunaweera, University of Colombo, Sri Lanka
James Kazura, Case Western Reserve University, U.S.A
11:30-12:00 Mass drug administration to eliminate malaria on islands
Akira Kaneko, NIID, Japan
12:0-12:30 Genomics and drug resistance mechanisms in Plasmodium falciparum population along the China-Myanmar border
Liwang Cui, Penn State University, U.S.A.
12:30-13:30 Lunch Break and Poster Viewing
13:30-14:00 Artemisinin and drug partner resistance: from phenotype to genotype
Didier Menard, Institut Pasteur in Cambodia, Cambodia
14:00-14:30 Topic: Molecular epidemiology of Plasmodium vivax malaria in Duffy-negative human in Ethiopia
Guiyun Yan, University of California, Irvine, U.S.A.
SESSION 6 Cancer, Infectious Agents, and Antibiotic Resistance
Moderators: Tohru Kiyono,National Cancer Center Research Institute, Japan
Ted Trimble, National Cancer Institute, U.S.A.
Rapporteurs: Marie Ricciardone, National Cancer Institute, U.S.A. Haruhiko Sugimura, Hamamatsu University School of Medicine, Japan
14:30-15:00 Topic: Helicobacter pylori and gastric cancer
Masanori Hatakeyama, University of Tokyo, Japan
15:10-15:40 Topic: Helicobacter pylori eradication for gastric cancer prevention
Il Ju Choi, National Cancer Center, Korea
15:40-16:10 Topic: The Human Microbiome, Gastric Cancer Prevention, and Antimicrobial Resistance
Christian Abnet, National Cancer Institute, U.S.A.
16:10-16:40 Topic: Contribution of liver fluke and diabetes on development and progression of cholangiocarcinoma
Sopit Wongkham, Khon Kaen University, Thailand
16:40-17:00 Masao Mitsuyama, Kyoto University, Japan
Parasitic Disease Panel
February 9, 2017
Venue: Novotel Ambassador in Seoul Gangnam, Republic of Korea
Thursday, 9 February 2017
WELCOMING REMARKS AND INTRODUCTION
9:00-9:10 Kenji Hirayama, Malla Rao
9:10-9:30 Strategic directions for future research in Parasitic Diseases
Malla Rao ? Secretariat, Parasitic Diseases Panel
Session Chairs: Drs. James Kazura and Kenji Hirayama
9:30-9:50 Identification of an AIGI gene as a novel virulence-associated gene by comparative genomics of Entamoeba histolytica clinical isolates
Kumiko Tsukui ? Senior Research Scientist, NIID
9:50-10:10 Uniqueness of the blood-stage malaria vaccine candidate BK-SE36
Toshihiro Horii - Professor, BIKEN,Osaka University
10:10-10:30 Discovery of novel erythrocyte binding proteins of Plasmodium vivax
Eun-Taek Han ? Professor, Kangwon National University School of Medicine, South Korea
10:50?11:10 Impact of maternal praziquantel treatment during pregnancy on offspring immune responses to schistosome antigens at six years of age in Leyte, Philippines: results from a randomized controlled trial.
Mario Jiz - Head Associate, RITM, Philippines
11:10-11:30 Screening for transmission-blocking vaccine candidates using the Plasmodium berghei model
Yaming Cao ? Professor, China Medical University, Shenyang
11:30-11:50 Genetic evidence for two genetically distinct zoonotic Plasmodium knowlesi parasites in Malaysia
Md Atique Ahmed ? Post Doc, Kangwon National University, South Korea
12:00-13:00 Lunch Break
Session Chairs: Drs. Takafumi Tsuboi and Malla Rao
13:00-13:20 PfGAMA, a novel blood-stage malaria vaccine candidate, associates directly with PfMSP10
Eizo Takashima ? Associate Professor, Proteo-Science Center, Ehime University
13:20-13:40 Crossborder malaria: A threat for malaria elimination in Bhutan
Tashi Tobgay - Director, Khesar Gyalpo Medical University of Bhutan
13:40-14:00 Plasmodium falciparum CSP vaccine based on a heterologous adenovirus-prime and baculovirus-boost immunization regimen confers sterile protection against transgenic P. berghei sporozoite challenge
Kunitaka Yoshida? Student,Kanazawa University
14:00-14:20 Transmission blocking in mutant malaria parasites resistance to antimalaria drug Atovaquone
Josephine E. Siregar - Research Fellow, Mitochondria and Infectious Diseases Lab.
14:20-14:40 Biochemical analysis of Plasmodium falciparum FJ180, a PHIST protein secreted into infected red blood cells
Takahiro Nakata ?Student, Proteo-Science Center, Ehime University
Session Chairs: Drs. Tomo Nozaki and Boris Striepen
15:00-15:20 Forward Genetic Screen for Host-Directed Therapy against Amebiasis
William Petri ? Professor, University of Virginia
15:20-15:40 IFN-? controls amebic liver abscess and the function of type 2 innate lymphoid cells in mice intraportally inoculated with Entamoeba histolytica
Shinjiro Hamano - Professor, NEKKEN
15:40-16:00 Characterizing malaria vector populations across three geographical setting in West Africa
Mamadou Coulibaly ? Researcher, University of Bamako
16:00-16:20 High throughput screening and combinatorial chemistry for the discovery of novel anti-malarials
Farhana Mosaddeque ? PhD Student, NEKKEN
16:20-16:40 Activation and exhaustion of antigen-specific CD8+ T cells occur in different splenic compartments during infection with Plasmodium berghei
Ganchimeg Bayarsaikhan ? Student ? Nagasaki University
Session Chairs: Dr. Kiyoshi Kita and Guiyun Yan
16:40-17:00 Characterization of the protein-protein interactions between PfRipr, Rh5 and CyRPA for logical design of blood-stage malaria vaccine
Hikaru Nagaoka ? Researcher, Proteo-Science Center, Ehime University
17:00-17:20 Discovery of lineage-specific mitosomal membrane proteins in Entamoeba histolytica
Santos Herbert Jiminez, Researcher, National Institute of Infectious Diseases
17:20-17:40 Application of antimalarial drugs for malaria biology
Takahiro Tougan ? Assistant Professor, BIKEN, Osaka University
17:40-18:00 Plasmodium Knowlesi Skeleton-Binding Protein 1 Localizes to the “Sinton and Mulligan” Stipplings in the Cytoplasm of Monkey and Human Erythrocytes
Lucky Amuza- PhD Student, NEKKEN
Copyright 2015 by The Korean Society for Parasitology and Tropical Medicine